Breast Cancer 1 MRI for breast cancer screening, diagnosis, and treatment

被引:310
作者
Morrow, Monica [1 ]
Waters, Janet [2 ]
Morris, Elizabeth [3 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, Breast Serv, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Med Lib, New York, NY 10065 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10065 USA
关键词
SURGICAL ADJUVANT BREAST; HIGH FAMILIAL RISK; CONTRALATERAL BREAST; NEOADJUVANT CHEMOTHERAPY; PREOPERATIVE MRI; TUMOR RESPONSE; CONSERVING SURGERY; ESTROGEN-RECEPTOR; MUTATION CARRIERS; WOMEN;
D O I
10.1016/S0140-6736(11)61350-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
MRI is used widely both for screening women who are at increased risk of breast cancer and for treatment selection. Prospective studies confirm that MRI screening of women with known or suspected genetic mutation results in a higher sensitivity for cancer detection than does mammography. However, survival data are not available. In women with breast cancer, MRI detects cancer not identified with other types of screening. In two randomised trials, this increased sensitivity did not translate into improved selection of surgical treatment or a reduction in the number of operations. Data for longer-term outcomes such as ipsilateral breast tumour recurrence rates and contralateral breast cancer incidence are scarce, but to date do not show clear benefit for MRI. MRI is better than other methods of assessing the response to neoadjuvant chemotherapy, and is helpful in identifying the primary tumour in patients who present with axillary adenopathy.
引用
收藏
页码:1804 / 1811
页数:8
相关论文
共 61 条
[51]   Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia [J].
Port, Elisa Rush ;
Park, Anna ;
Borgen, Patrick I. ;
Morris, Elizabeth ;
Montgomery, Leslie L. .
ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (03) :1051-1057
[52]   Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in fatty and dense breasts using the whole-breast pathologic examination as a gold standard [J].
Sardanelli, F ;
Giuseppetti, GM ;
Panizza, P ;
Bazzocchi, M ;
Fausto, A ;
Simonetti, G ;
Lattanzio, V ;
Del Maschio, A .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2004, 183 (04) :1149-1157
[53]   American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography [J].
Saslow, Debbie ;
Boetes, Carla ;
Burke, Wylie ;
Harms, Steven ;
Leach, Martin O. ;
Lehman, Constance D. ;
Morris, Elizabeth ;
Pisano, Etta ;
Schnall, Mitchell ;
Sener, Stephen ;
Smith, Robert A. ;
Warner, Ellen ;
Yaffe, Martin ;
Andrews, Kimberly S. ;
Russell, Christy A. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2007, 57 (02) :75-89
[54]   Does MRI predict pathologioc tumor response in women with breast cancer undergoing preoperative chemotherapy? [J].
Segara, Davendra ;
Krop, Ian E. ;
Garber, Judy E. ;
Winer, Eric ;
Harris, Lyndsay ;
Bellon, Jennifer R. ;
Birdwell, Robyn ;
Lester, Susan ;
Lipsitz, Stuart ;
Iglehart, J. Dirk ;
Golshan, Mehra .
JOURNAL OF SURGICAL ONCOLOGY, 2007, 96 (06) :474-480
[55]   Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ [J].
Solin, Lawrence J. ;
Orel, Susan G. ;
Hwang, Wei-Ting ;
Harris, Eleanor E. ;
Schnall, Mitchell D. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (03) :386-391
[56]   Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial [J].
Turnbull, Lindsay ;
Brown, Sarah ;
Harvey, Ian ;
Olivier, Catherine ;
Drew, Phil ;
Napp, Vicky ;
Hanby, Andrew ;
Brown, Julia .
LANCET, 2010, 375 (9714) :563-571
[57]   Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination [J].
Warner, E ;
Plewes, DB ;
Hill, KA ;
Causer, PA ;
Zubovits, JT ;
Jong, RA ;
Cutrara, MR ;
DeBoer, G ;
Yaffe, MJ ;
Messner, SJ ;
Meschino, WS ;
Piron, CA ;
Narod, SA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (11) :1317-1325
[58]   Systematic review: Using magnetic resonance imaging to screen women at high risk for breast cancer [J].
Warner, Ellen ;
Messersmith, Hans ;
Causer, Petrina ;
Eisen, Andrea ;
Shumak, Rene ;
Plewes, Donald .
ANNALS OF INTERNAL MEDICINE, 2008, 148 (09) :671-679
[59]   Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy? [J].
Warren, RML ;
Bobrow, LG ;
Earl, HM ;
Britton, PD ;
Gopalan, D ;
Purushotham, AD ;
Wishart, GC ;
Benson, JR ;
Hollingworth, W .
BRITISH JOURNAL OF CANCER, 2004, 90 (07) :1349-1360
[60]   Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer [J].
Yeh, E ;
Slanetz, P ;
Kopans, DB ;
Rafferty, E ;
Georgian-Smith, D ;
Moy, L ;
Halpern, E ;
Moore, R ;
Kuter, I ;
Taghian, A .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2005, 184 (03) :868-877